Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-24 @ 11:31 PM
NCT ID:
NCT04947956
Brief Title:
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma
Official Title:
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma in China: a Real-world Study
Study:
NCT04947956
Protocol Section:
NCT04947956